<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; tech</title>
	<atom:link href="http://www.tapanray.in/tag/tech/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>New Digital Tools To Protect From Infection, Neutralize Covid-19</title>
		<link>http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=new-digital-tools-to-protect-from-infection-neutralize-covid-19</link>
		<comments>http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/#comments</comments>
		<pubDate>Mon, 03 Aug 2020 00:00:53 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[Availability]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Devices]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infection]]></category>
		<category><![CDATA[initiatives]]></category>
		<category><![CDATA[neutralize]]></category>
		<category><![CDATA[overworked]]></category>
		<category><![CDATA[prevent]]></category>
		<category><![CDATA[protect]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Shycocan]]></category>
		<category><![CDATA[spread]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tech]]></category>
		<category><![CDATA[technological]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[transmission]]></category>
		<category><![CDATA[workers]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10209</guid>
		<description><![CDATA[There seems to be some light at the end of the dark tunnel of a serious biological threat that the world is passing through, since the nightmarish last seven months. The COVID-19 pandemic has spread to 213 countries and territories, and the number &#8230; <a href="http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma To Facilitate Self-Managing Chronic Diseases For Better Outcomes?</title>
		<link>http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes</link>
		<comments>http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/#comments</comments>
		<pubDate>Mon, 07 Jan 2019 00:00:48 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ailments]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[apps]]></category>
		<category><![CDATA[behavioral]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[chronic. diseases]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[facilitate]]></category>
		<category><![CDATA[Google]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[incidence]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[mHealth]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[NCDs]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[self-managing]]></category>
		<category><![CDATA[startups]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tech]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[unmet]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9342</guid>
		<description><![CDATA[“India&#8217;s burden of non-communicable disease (NCD) is escalating, but still the country does not have sufficiently detailed data on NCDs for research and policy purposes.” This was captured in a recent study, titled “India&#8217;s escalating burden of non-communicable diseases,” published in The Lancet Global Health on &#8230; <a href="http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Next Frontier: Frugal Innovation For High-Tech Drugs</title>
		<link>http://www.tapanray.in/the-next-frontier-frugal-innovation-for-high-tech-drugs/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-next-frontier-frugal-innovation-for-high-tech-drugs</link>
		<comments>http://www.tapanray.in/the-next-frontier-frugal-innovation-for-high-tech-drugs/#comments</comments>
		<pubDate>Mon, 30 May 2016 00:00:42 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ABBvie]]></category>
		<category><![CDATA[arbitrary]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Essential]]></category>
		<category><![CDATA[facade]]></category>
		<category><![CDATA[Frugal]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[life]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Models]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[saving]]></category>
		<category><![CDATA[Stemcentrx]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tech]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7655</guid>
		<description><![CDATA[Should drug innovation models remain as expensive as what these are claimed to be now by the global pharma industry, in general? Finding a credible, appropriately quantifiable, and generally acceptable answer to this question is critical. It won’t, then, just &#8230; <a href="http://www.tapanray.in/the-next-frontier-frugal-innovation-for-high-tech-drugs/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-next-frontier-frugal-innovation-for-high-tech-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
